tradingkey.logo
tradingkey.logo
Buscar

Conexeu Sciences Ord Shs

CNXU
Añadir a la lista de seguimiento
2.180USD
0.0000.00%
Cierre 11-13 16:00(ET)
67.21MCap. mercado
0.00P/E TTM

Acerca de Conexeu Sciences Ord Shs Compañía

Conexeu Sciences Inc. is an early-stage medical technology company. The Company is focused on developing regenerative biomaterials that address significant needs in wound care, dentistry, and aesthetics. The Company is focused on providing physicians with device-based solutions for healing, restoring soft tissue, and improving patient outcomes across multiple clinical settings. Its core device candidate, CXU, is a temperature-responsive ECM scaffold formulation intended to transition in-situ to a gel-like extra cellular matrix (ECM) within approximately minutes (Ten-Minute Tissue). The Company operates and manages its business in one operating segment, which is developing and commercializing novel cellular therapies for skin restoration in wound care and aesthetics.

Perfil de Conexeu Sciences Ord Shs

Símbolo de cotización- -
Nombre de la empresa- -
Fecha de salida a bolsa- -
Director ejecutivo- -
Número de empleados- -
Tipo de seguridad- -
Fin del año fiscal- -
Dirección- -
Ciudad- -
Bolsa de valores- -
País- -
Código postal- -
Teléfono- -
Sitio Web- -
Símbolo de cotización- -
Fecha de salida a bolsa- -
Director ejecutivo- -

Ejecutivos de Conexeu Sciences Ord Shs

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David Bogart
Mr. David Bogart
Chief Commercial Officer, Co-Founder, Director
Chief Commercial Officer, Co-Founder, Director
2.24M
+33.43%
Mr. David Bogart
Mr. David Bogart
Chief Commercial Officer, Co-Founder, Director
Chief Commercial Officer, Co-Founder, Director
2.24M
+33.43%
Mr. David Bogart
Mr. David Bogart
Chief Commercial Officer, Co-Founder, Director
Chief Commercial Officer, Co-Founder, Director
2.24M
+33.43%
Mr. Miles Harrison
Mr. Miles Harrison
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
237.86K
--
Mr. Miles Harrison
Mr. Miles Harrison
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
237.86K
--
Mr. Miles Harrison
Mr. Miles Harrison
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
237.86K
--
Mr. Jeff Sharpe
Mr. Jeff Sharpe
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Mr. Steve D. Inouye
Mr. Steve D. Inouye
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
--
--
Ms. Ana Bastiani
Ms. Ana Bastiani
Director
Director
--
--
Ms. April Burke
Ms. April Burke
Director
Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David Bogart
Mr. David Bogart
Chief Commercial Officer, Co-Founder, Director
Chief Commercial Officer, Co-Founder, Director
2.24M
+33.43%
Mr. David Bogart
Mr. David Bogart
Chief Commercial Officer, Co-Founder, Director
Chief Commercial Officer, Co-Founder, Director
2.24M
+33.43%
Mr. David Bogart
Mr. David Bogart
Chief Commercial Officer, Co-Founder, Director
Chief Commercial Officer, Co-Founder, Director
2.24M
+33.43%
Mr. Miles Harrison
Mr. Miles Harrison
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
237.86K
--
Mr. Miles Harrison
Mr. Miles Harrison
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
237.86K
--
Mr. Miles Harrison
Mr. Miles Harrison
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
237.86K
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Conexeu Sciences Ord Shs?

Los cinco principales accionistas de Conexeu Sciences Ord Shs son: Mr. David Bogart
tradingkey.logo
Advertencia de Riesgo: Nuestro sitio web y aplicación móvil solo proporcionan información general sobre ciertos productos de inversión. Finsights no proporciona, y la provisión de dicha información no debe interpretarse como que Finsights proporciona, asesoramiento financiero o recomendación para cualquier producto de inversión.
Los productos de inversión están sujetos a riesgos de inversión significativos, incluida la posible pérdida del monto principal invertido y pueden no ser adecuados para todos. El rendimiento pasado de los productos de inversión no es indicativo de su rendimiento futuro.
Finsights puede permitir que anunciantes o afiliados de terceros coloquen o entreguen anuncios en nuestro sitio web o aplicación móvil o en cualquier parte de los mismos y puede ser compensado por ellos en función de su interacción con los anuncios.
© Derechos de autor: FINSIGHTS MEDIA PTE. LTD. Todos los derechos reservados.